Sandisk Announces Pricing of Upsized Secondary Offering of Common Stock — Neutral
SNDK Business Wire — June 06, 2025MILPITAS, Calif.--(BUSINESS WIRE)--Sandisk Corporation (Nasdaq: SNDK) (the “Company” or “Sandisk”) announced today the pricing of a secondary public offering (the “Offering”) of 18,534,581 shares of its common stock (the “SNDK Shares”) currently owned by Western Digital Corporation, the Company's former parent (“WDC”). The size of the offering reflects an increase from the 17,000,000 shares of common stock originally proposed to be sold. The SNDK Shares will be offered at a public offering pric.

NSSC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that NAPCO Security Technologies, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
NSSC Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against NAPCO Security Technologies, Inc. ("NAPCO" or "the Company") (NASDAQ:NSSC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired NAPCO securities between February 5, 2024 and February 3, 2025, both dates inclusive (the "Class Period").

TMCI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Treace Medical Concepts, Inc. to Contact the Firm Today! — Neutral
TMCI Accesswire — June 06, 2025NEW YORK CITY, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Treace Medical securities between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period").

NPWR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that NET Power Inc. Investors Have Opportunity to Lead Class Action Lawsuit! — Neutral
NPWR Accesswire — June 06, 2025NEW YORK CITY, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against NET Power Inc. ("NET Power" or "the Company") (NYSE:NPWR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired NET Power securities between June 9, 2023 and March 7, 2025, both dates inclusive (the "Class Period").

CAR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Avis Budget Group, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
CAR Accesswire — June 06, 2025NEW YORK CITY, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period").

ZBIO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zenas BioPharma, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! — Neutral
ZBIO Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Zenas BioPharma, Inc. ("Zenas BioPharma" or "the Company") (NASDAQ:ZBIO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zenas BioPharma securities pursuant to the registration statement and prospectus issued in connection with the Company's September 13, 2024 initial public offering ("IPO").

IBTA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ibotta, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! — Neutral
IBTA Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ibotta, Inc. ("Ibotta" or "the Company") (NYSE:IBTA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of: (1) all persons or entities who purchased or otherwise acquired publicly traded Ibotta, Inc. ("Ibotta" or the "Company") securities pursuant and/or traceable to the Company's Registration Statement on Form S-1 (including all amendments made thereto) …

June's Best Blue-Chip Fat Pitches: Opportunities Hiding In Plain Sight — Positive
AES AMZN ARE NVDA O Seeking Alpha — June 06, 2025For my Top 5 ideas list, I focus on Buffett-style "fat pitch" blue-chip bargains: Wonderful companies at wonderful prices, based on fundamentals, not technicals or short-term sentiment. A disciplined, fundamentals-driven approach uses historical fair value multiples and consensus analyst data. My Top 5 Buy List for June - AES, ARE, AMZN, NVDA, and O - offers a 49% historical discount and over 100% return potential if they revert to fair value.

ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform — Neutral
PRPH GlobeNewsWire — June 06, 2025UNIONDALE, NY, June 06, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced the formation of its Clinical Science Advisory Board to support the clinical adoption and commercialization of its breakthrough BE-SmartTM molecular test for esophageal disease. The advisory board will provide expert strategic guidance as ProPhase leads the regulatory and commercialization pathway for BE-Smart, with the goal of establishing a new clinical and economic standard in the early detection and management of esophageal cancer risk.

Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment — Positive
BMY BNTX Seeking Alpha — June 06, 2025Bristol-Myers Squibb is attractively valued, offers a 5%+ dividend yield, and benefits from a strong oncology pipeline after its BioNTech deal. The $11B BioNTech partnership gives BMY access to BNT327, targeting large cancer markets, with a deal structure that limits BMY's downside risk. BMY's established cash flows, low payout ratio, and current low valuation make it a safer, income-generating pick versus higher-risk, growth-oriented BioNTech.

BBAI Stockholders Have Opportunity to Lead BigBear.ai Holdings, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! — Neutral
BBAI Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against BigBear.ai Holdings, Inc. ("BigBear" or "the Company") (NYSE:BBAI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired BigBear securities between March 31, 2022 and March 25, 2025, both dates inclusive (the "Class Period").

3 Passive 'SWAN' Stocks (Hint: They're Not REITs) — Positive
ES OKE PNC Seeking Alpha — June 06, 2025Buying and holding companies that provide reliable streams of passive income can help an investor stay one step ahead of bills. In today's article, I'll highlight a major midstream player, an electric and gas utility, and a super-regional bank/financial services company. Relative to my fair value estimates, the stocks vary from 9% to 16% discounted.

Strategy Announces Pricing of Initial Public Offering of STRD Stock — Neutral
MSTR Business Wire — June 06, 2025TYSONS CORNER, Va.--(BUSINESS WIRE)--Strategy™ (Nasdaq: MSTR/STRK/STRF) today announced the pricing of its initial public offering on June 5, 2025 of 11,764,700 shares of 10.00% Series A Perpetual Stride Preferred Stock (the “STRD Stock”), at a public offering price of $85.00 per share. The issuance and sale of the STRD Stock are scheduled to settle on June 10, 2025, subject to customary closing conditions. Strategy estimates that the net proceeds to it from the offering will be approximately $.

BRMK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Broadmark Realty Capital Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
BRMK RC Accesswire — June 06, 2025NEW YORK CITY, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Broadmark Realty Capital Inc. ("Broadmark" or "the Company") (NYSE:BRMK), Ready Capital Corporation ("Ready Capital") (NYSE:RC), and certain officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that held Broadmark common stock as of the record date of the May 30, 2023 (the "Merger Date") between Broadmark and Ready Capital, were …

LPRO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Open Lending Corporation Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
LPRO Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Open Lending Corporation ("Open Lending" or "the Company") (NASDAQ:LPRO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Open Lending securities between February 24, 2022 and March 31, 2025, both dates inclusive (the "Class Period").

CIVI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Civitas Resources, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
CIVI Accesswire — June 06, 2025NEW YORK CITY, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Civitas Resources, Inc. ("Civitas" or "the Company") (NYSE:CIVI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Civitas securities between February 27, 2024 and February 24, 2025, both dates inclusive (the "Class Period").

WST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
WST Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").

CODI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Compass Diversified Holdings to Contact the Firm Today! — Neutral
CODI Accesswire — June 06, 2025NEW YORK CITY, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Compass Diversified Holdings ("Compass" or "the Company") (NYSE:CODI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Compass securities between May 1, 2024 and May 7, 2025, both dates inclusive (the "Class Period").

DV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DoubleVerify Holdings, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! — Neutral
DV Accesswire — June 06, 2025NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DoubleVerify Holdings, Inc. ("DoubleVerify" or "the Company") (NYSE:DV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired DoubleVerify securities between November 10, 2023 and February 27, 2025, both dates inclusive (the "Class Period").

OGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Organon & Co. Stockholders Have Opportunity to Lead Class Action Lawsuit! — Neutral
OGN Accesswire — June 06, 2025NEW YORK CITY, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Organon & Co. ("Organon" or "the Company") (NYSE:OGN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Organon securities between October 31, 2024 and April 30, 2025, both dates inclusive (the "Class Period").
